Cargando…

Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma

OBJECTIVE: Previous studies have evaluated various markers as prognostic predictors in patients with many types of cancers. However, the influence of such factors on the outcomes of patients with parotid gland carcinoma (PGC) is unknown. This study investigated the roles of alternative markers in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikoshiba, Takuya, Ozawa, Hiroyuki, Watanabe, Yoshihiro, Sekimizu, Mariko, Saito, Shin, Yoshihama, Keisuke, Nakamura, Shintaro, Imanishi, Yorihisa, Kameyama, Kaori, Ogawa, Kaoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891395/
https://www.ncbi.nlm.nih.gov/pubmed/32673437
http://dx.doi.org/10.1002/lary.28934
_version_ 1783652690027347968
author Mikoshiba, Takuya
Ozawa, Hiroyuki
Watanabe, Yoshihiro
Sekimizu, Mariko
Saito, Shin
Yoshihama, Keisuke
Nakamura, Shintaro
Imanishi, Yorihisa
Kameyama, Kaori
Ogawa, Kaoru
author_facet Mikoshiba, Takuya
Ozawa, Hiroyuki
Watanabe, Yoshihiro
Sekimizu, Mariko
Saito, Shin
Yoshihama, Keisuke
Nakamura, Shintaro
Imanishi, Yorihisa
Kameyama, Kaori
Ogawa, Kaoru
author_sort Mikoshiba, Takuya
collection PubMed
description OBJECTIVE: Previous studies have evaluated various markers as prognostic predictors in patients with many types of cancers. However, the influence of such factors on the outcomes of patients with parotid gland carcinoma (PGC) is unknown. This study investigated the roles of alternative markers in the prognoses of patients with PGC. METHODS: Overall, 101 patients who underwent curative treatment for PGC were retrospectively evaluated, and their 5‐year overall and disease‐free survival rates were calculated. The prognostic values of clinical and pathologic factors were determined. RESULTS: The 5‐year overall and disease‐free survival rates were 73.1% and 62.8%, respectively. Multivariate analysis revealed that a low lymphocyte‐to‐monocyte ratio (LMR), high T classification, high N classification, and perineural invasion were independent predictors of poor prognosis. CONCLUSIONS: Thus, we identified LMR as an independent prognostic factor for patients with PGC. Patients with low LMRs who are amenable to treatment may require adjuvant treatment to improve their prognoses. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E864–E869, 2021
format Online
Article
Text
id pubmed-7891395
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78913952021-03-02 Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma Mikoshiba, Takuya Ozawa, Hiroyuki Watanabe, Yoshihiro Sekimizu, Mariko Saito, Shin Yoshihama, Keisuke Nakamura, Shintaro Imanishi, Yorihisa Kameyama, Kaori Ogawa, Kaoru Laryngoscope Head and Neck OBJECTIVE: Previous studies have evaluated various markers as prognostic predictors in patients with many types of cancers. However, the influence of such factors on the outcomes of patients with parotid gland carcinoma (PGC) is unknown. This study investigated the roles of alternative markers in the prognoses of patients with PGC. METHODS: Overall, 101 patients who underwent curative treatment for PGC were retrospectively evaluated, and their 5‐year overall and disease‐free survival rates were calculated. The prognostic values of clinical and pathologic factors were determined. RESULTS: The 5‐year overall and disease‐free survival rates were 73.1% and 62.8%, respectively. Multivariate analysis revealed that a low lymphocyte‐to‐monocyte ratio (LMR), high T classification, high N classification, and perineural invasion were independent predictors of poor prognosis. CONCLUSIONS: Thus, we identified LMR as an independent prognostic factor for patients with PGC. Patients with low LMRs who are amenable to treatment may require adjuvant treatment to improve their prognoses. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:E864–E869, 2021 John Wiley & Sons, Inc. 2020-07-16 2021-03 /pmc/articles/PMC7891395/ /pubmed/32673437 http://dx.doi.org/10.1002/lary.28934 Text en © 2020 The Authors. The Laryngoscope published by Wiley Periodicals LLC. on behalf of The American Laryngological, Rhinological and Otological Society, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Head and Neck
Mikoshiba, Takuya
Ozawa, Hiroyuki
Watanabe, Yoshihiro
Sekimizu, Mariko
Saito, Shin
Yoshihama, Keisuke
Nakamura, Shintaro
Imanishi, Yorihisa
Kameyama, Kaori
Ogawa, Kaoru
Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
title Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
title_full Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
title_fullStr Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
title_full_unstemmed Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
title_short Prognostic Value of the Lymphocyte‐to‐Monocyte Ratio in Patients with Parotid Gland Carcinoma
title_sort prognostic value of the lymphocyte‐to‐monocyte ratio in patients with parotid gland carcinoma
topic Head and Neck
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891395/
https://www.ncbi.nlm.nih.gov/pubmed/32673437
http://dx.doi.org/10.1002/lary.28934
work_keys_str_mv AT mikoshibatakuya prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT ozawahiroyuki prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT watanabeyoshihiro prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT sekimizumariko prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT saitoshin prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT yoshihamakeisuke prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT nakamurashintaro prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT imanishiyorihisa prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT kameyamakaori prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma
AT ogawakaoru prognosticvalueofthelymphocytetomonocyteratioinpatientswithparotidglandcarcinoma